Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2910342 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2010 | 4 Pages |
Abstract
We conclude that surfonylureas treatment leads to increased insulin and leptin levels in overweight type 2 diabetes men, metformin, or rosiglitazone treatment can reduce insulin and leptin levels, respectively, and effect of metformin on plasma leptin and insulin levels is more significant than that of rosiglitazone.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ming Zhao, Jia-Qing Shao, Hong Du,